Rhumbline Advisers Nkarta, Inc. Transaction History

Rhumbline Advisers

$104 Billion
Q1 2025

A detailed history of Rhumbline Advisers transactions in Nkarta, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 78,185 shares of NKTX stock, worth $144,642. This represents 0.0% of its overall portfolio holdings.

Number of Shares

78,185

Previous 81,191 3.7%

Holding current value

$144,642

Previous $202,000 22.77%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 08, 2025	SELL	$1.37 - $2.53 $4,118 - $7,605	-3,006 Reduced 3.7%	78,185 $156,000
Q4 2024 Jan 30, 2025	BUY	$2.17 - $4.34 $4,632 - $9,265	2,135 Added 2.7%	81,191 $202,000
Q3 2024 Nov 12, 2024	SELL	$4.52 - $8.0 $22,396 - $39,640	-4,955 Reduced 5.9%	79,056 $357,000
Q2 2024 Aug 01, 2024	BUY	$5.27 - $10.82 $174,526 - $358,325	33,117 Added 65.07%	84,011 $496,000
Q1 2024 May 09, 2024	BUY	$5.59 - $15.71 $8,742 - $24,570	1,564 Added 3.17%	50,894 $550,000
Q3 2023 Nov 09, 2023	SELL	$1.39 - $2.29 $275 - $453	-198 Reduced 0.4%	49,330 $68,000
Q2 2023 Aug 08, 2023	SELL	$2.19 - $5.17 $3,740 - $8,830	-1,708 Reduced 3.33%	49,528 $108,000
Q1 2023 May 11, 2023	SELL	$3.37 - $6.3 $1,513 - $2,828	-449 Reduced 0.87%	51,236 $182,000
Q4 2022 Feb 14, 2023	BUY	$5.14 - $14.35 $4,343 - $12,125	845 Added 1.66%	51,685 $310,000
Q3 2022 Nov 10, 2022	BUY	$12.27 - $18.39 $34,466 - $51,657	2,809 Added 5.85%	50,840 $669,000
Q2 2022 Aug 11, 2022	BUY	$7.77 - $19.44 $233,978 - $585,396	30,113 Added 168.06%	48,031 $592,000
Q1 2022 May 12, 2022	SELL	$8.66 - $14.99 $14,297 - $24,748	-1,651 Reduced 8.44%	17,918 $204,000
Q4 2021 Feb 10, 2022	SELL	$12.79 - $26.88 $6,497 - $13,655	-508 Reduced 2.53%	19,569 $300,000
Q3 2021 Nov 12, 2021	BUY	$26.67 - $38.76 $18,002 - $26,163	675 Added 3.48%	20,077 $558,000
Q2 2021 Aug 05, 2021	SELL	$23.94 - $36.68 $35,143 - $53,846	-1,468 Reduced 7.03%	19,402 $615,000
Q1 2021 May 06, 2021	BUY	$31.33 - $59.61 $71,213 - $135,493	2,273 Added 12.22%	20,870 $687,000
Q4 2020 Feb 10, 2021	BUY	$27.03 - $75.62 $86,468 - $241,908	3,199 Added 20.78%	18,597 $1.14 Million
Q3 2020 Nov 12, 2020	BUY	$23.52 - $47.9 $362,160 - $737,564	15,398 New	15,398 $463,000

Others Institutions Holding NKTX

# of Institutions

119

Shares Held

61.1M

Call Options Held

17.6K

Put Options Held

1.11M

View Full List

About Nkarta, Inc.

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $90M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

More about NKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Nkarta, Inc. Transaction History